Erleva 150mg Tablet

Erleva is targeted therapy. Erleva is classified as an epidermal growth factor receptor (EGFR) inhibitor - protein-tyrosine kinase inhibitor. It works by helping to stop cancer cells from growing.

Erleva 150mg Uses :

• Treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).
• Treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.

Erleva works by slowing cancer cell growth. It binds to a certain protein (epidermal growth factor receptor-EGFR) in some tumors.

Common Side Effects of Erleva 150mg Tablet:

Nausea, vomiting, loss of appetite, mouth sores, dry skin, eye dryness/irritation, or unusual eyelash growth may occur. Changes in diet such as eating several small meals or limiting activity may help lessen the chance of nausea. If any of these effects persist or worsen, notify your doctor or pharmacist promptly.

Tell your doctor right away if any of these rare but very serious side effects occur: signs of kidney problems (such as change in the amount of urine), black stools, vomit that looks like coffee grounds, easy bleeding/bruising, stomach/abdominal pain, yellowing eyes or skin, dark urine, unusual fatigue, signs of infection (e.g., fever, chills, persistent sore throat), eye pain, vision changes.

This is not a complete list of possible side effects.

How to Order Erleva (Erlotinib) 150mg Tablets from India

If you wish to order Erleva Erlotinib 150mg tablets online from India at an affordable price, you just have to fill the "ASK Price" form. We will get in touch with you as soon as your order gets placed.

LetsMeds is a leading exporter, supplier & distributor of Erleva Erlotinib 150mg Tablets manufactured by Glenmark Pharmaceuticals from India. We export Erleva Erlotinib 150mg tablets to China, Russia, Hong Kong, UK, USA, Vietnam, Ukraine, Singapore, Philippines, UAE, Saudi Arabia, Morocco, and other countries. To know more call us at +91-9205576166 or email at LetsMeds@gmail.com